Jiangsu Apon Medical Technology Co 300753.SZ · CNY

Its shares trade on Shenzhen under the ticker 300753.SZ. It has been listed since 13 December 2018. In the fiscal year to 31 December 2025, it reported revenue of CN¥342.0m and a net loss of CN¥24.0m. At that date it held total assets of CN¥859.7m and shareholders' equity of CN¥667.4m.

Jiangsu Apon Medical Technology Co., Ltd. engages in the research, development, production, and sale of medical device products for pain management and nasal care. The company is headquartered in Nantong, Jiangsu. The company went IPO on 2018-12-13. The firm's main products include medical devices such as micro-computer injection pumps, disposable drug injection pumps, wireless analgesia management systems, pulse oximeters and sensors for pain management, and nasal care applications such as nasal care sprayers. Among them, medical devices used in the field of pain management are mainly used for infusion and monitoring of drug treatment in postoperative, childbirth, cancer and other clinical treatments to alleviate pain in patients; medical devices used in nasal care are mainly used to relieve nasal dryness, nasal congestion and nose discomfort such as bleeding in patients. The firm operates primarily in domestic and overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Yufei YeSecretary of the Board

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.